AAAAAA

   
Results: 1-11 |
Results: 11
ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE
Authors: REDDISH MA MACLEAN GD KOGANTY RR KANMITCHELL J JONES V MITCHELL MS LONGENECKER BM
Citation: Ma. Reddish et al., ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE, International journal of cancer, 76(6), 1998, pp. 817-823
PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS
Authors: MACLEAN GD REDDISH MA LONGENECKER BM
Citation: Gd. Maclean et al., PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 70-78
DEPLOYMENT AND EVALUATION OF A SYSTEM FOR GROUND-BASED MEASUREMENT OFCLOUD LIQUID WATER TURBULENT FLUXES
Authors: KOWALSKI AS ANTHONI PM VONG RJ DELANY AC MACLEAN GD
Citation: As. Kowalski et al., DEPLOYMENT AND EVALUATION OF A SYSTEM FOR GROUND-BASED MEASUREMENT OFCLOUD LIQUID WATER TURBULENT FLUXES, Journal of atmospheric and oceanic technology, 14(3), 1997, pp. 468-479
RADIOIMMUNOSCINTIGRAPHY IN PATIENTS WITH BREAST ADENOCARCINOMA USING TC-99M LABELED MONOCLONAL-ANTIBODY 170H.82 - REPORT OF A PHASE-II STUDY
Authors: MCQUARRIE SA MACLEAN GD BONIFACE GR GOLBERG K MCEWAN AJB
Citation: Sa. Mcquarrie et al., RADIOIMMUNOSCINTIGRAPHY IN PATIENTS WITH BREAST ADENOCARCINOMA USING TC-99M LABELED MONOCLONAL-ANTIBODY 170H.82 - REPORT OF A PHASE-II STUDY, European journal of nuclear medicine, 24(4), 1997, pp. 381-389
ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE
Authors: MACLEAN GD MILES DW RUBENS RD REDDISH MA LONGENECKER BM
Citation: Gd. Maclean et al., ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 309-316
ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE
Authors: MACLEAN GD REDDISH MA KOGANTY RR LONGENECKER BM
Citation: Gd. Maclean et al., ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 59-68
PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL)
Authors: REDDISH MA MACLEAN GD POPPEMA S BERG A LONGENECKER BM
Citation: Ma. Reddish et al., PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL), Cancer immunology and immunotherapy, 42(5), 1996, pp. 303-309
PHASE-II STUDY TO EVALUATE THE TOXICITY AND EFFICACY OF CONCURRENT CISPLATIN AND RADIATION-THERAPY IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX
Authors: PEARCEY RG STUART GCE MACLEAN GD NATION JG ARTHUR K LUKKA H JEFFREY J JAMES K BRUNDAGE M
Citation: Rg. Pearcey et al., PHASE-II STUDY TO EVALUATE THE TOXICITY AND EFFICACY OF CONCURRENT CISPLATIN AND RADIATION-THERAPY IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX, Gynecologic oncology, 58(1), 1995, pp. 34-41
CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA)
Authors: YACYSHYN MBB POPPEMA S BERG A MACLEAN GD REDDISH MA MEIKLE A LONGENECKER BM
Citation: Mbb. Yacyshyn et al., CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA), International journal of cancer, 61(4), 1995, pp. 470-474
PROSPECTS FOR AN IMMUNOLOGICAL APPROACH TO THERAPY OF OVARIAN-CANCER
Authors: MACLEAN GD LONGENECKER BM
Citation: Gd. Maclean et Bm. Longenecker, PROSPECTS FOR AN IMMUNOLOGICAL APPROACH TO THERAPY OF OVARIAN-CANCER, CLINICAL IMMUNOTHERAPEUTICS, 2(6), 1994, pp. 409-414
ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS
Authors: MACLEAN GD REDDISH MA BOWENYACYSHYN MB POPPEMA S LONGENECKER BM
Citation: Gd. Maclean et al., ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS, Cancer investigation, 12(1), 1994, pp. 46-56
Risultati: 1-11 |